SAN DIEGO and MENLO PARK, Calif., July 18, 2017 (GLOBE NEWSWIRE) — Novogene, a leading global provider of genomic services and solutions, and Pacific Biosciences of California, Inc. (NASDAQ:PACB), the…
MENLO PARK, Calif., June 22, 2017 (GLOBE NEWSWIRE) — A new publication in Nature reveals the significant quality improvement afforded by Single Molecule, Real-Time (SMRT®) Sequencing for the maize genome,…
MENLO PARK, Calif., June 15, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:PACB) (the “Company”) today announced that it has priced its previously announced underwritten public offering of…
MENLO PARK, Calif., June 14, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced that it intends to offer and sell shares of its common stock in…
MENLO PARK, Calif., May 22, 2017 (GLOBE NEWSWIRE) — A series of recent peer-reviewed scientific publications highlights the growing use of Single Molecule, Real-Time (SMRT®) Sequencing to annotate plant and…
MENLO PARK, Calif., April 26, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced financial results for its first quarter ended March 31, 2017. Product and service…
MENLO PARK, Calif., April 18, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:PACB) will hold its quarterly conference call to discuss its First Quarter 2017 Financial Results on…
Customers Demonstrate Value of PacBio Long-Read Solutions for Resolving Structural Variants, Targeted Sequencing and Isoform Sequencing Applications MENLO PARK, Calif., Feb. 13, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California,…
MENLO PARK, Calif., Feb. 02, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced financial results for its fourth quarter ended December 31, 2016. Revenue for the…
MENLO PARK, Calif., Jan. 27, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:PACB) will hold its quarterly conference call to discuss its Fourth Quarter 2016 Financial Results on…
MENLO PARK, Calif., and BEIJING, Jan. 16, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB) and Novogene Corporation, a leading provider of genomic and bioinformatic services, today announced…
MENLO PARK, Calif., Jan. 12, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB) today announced that its Single Molecule, Real-Time (SMRT®) Sequencing technology will be featured in at…
MENLO PARK, Calif., Jan. 09, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB) today announced a new version of chemistry (V2) and software (V4) for the Sequel™ System….
MENLO PARK, Calif. and BEIJING, Jan. 04, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), today announced that GrandOmics Biosciences Co., Ltd of Beijing, through its subsidiary NextOmics…
MENLO PARK, Calif., Dec. 15, 2016 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), today announced that F. Hoffman-La Roche Ltd (Roche) has elected to terminate for convenience the…
If you have a question, need to check the status of an order, or are interested in purchasing an instrument, we're here to help.